Previous close | 4.7000 |
Open | 4.6800 |
Bid | 4.3400 x N/A |
Ask | 4.4000 x N/A |
Day's range | 4.6800 - 4.6800 |
52-week range | 3.6600 - 8.5500 |
Volume | |
Avg. volume | 1,099 |
Market cap | 591.435M |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Exscientia's significant individual investors ownership suggests that the key decisions are influenced by...
The chief executive and founder of an Oxford-based drug company has been sacked over “inappropriate” relationships with colleagues.
British biotech Exscientia Plc said on Tuesday it had dismissed CEO Andrew Hopkins after an investigation found that his relationship with two employees was "inconsistent with the company's standards and values". Exscientia said a special committee of its board had engaged an outside counsel to look into Hopkins' conduct. The company said Chairman David Nicholson resigned from the board on Feb. 12 after it was discovered during the investigation that Nicholson had prior knowledge about one of Hopkins' relationships.